Capecitabine-Induced Coronary Vasospasm: A Case Report

Angiology

Volumn 55, Issue 1, 2004, Pages 93-97

  Rizvi, Asad A ^a   Schauer, Peter ^a   Owlia, Dariush ^a   Kallal, James E ^a,b  

^a HARTFORD HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; CAPECITABINE; CETUXIMAB; DEOXYCYTIDINE; DILTIAZEM; DRUG DERIVATIVE; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; ISOSORBIDE MONONITRATE; NITRATE; OXALIPLATIN; WARFARIN;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOTOXICITY; CASE REPORT; COLON CANCER; COLORECTAL TUMOR; CORONARY ARTERY SPASM; DEEP VEIN THROMBOSIS; DIAPHORESIS; ELECTROCARDIOGRAM; HEART LEFT VENTRICLE; HUMAN; IATROGENIC DISEASE; MALE; NEUROTOXICITY; PATHOLOGY; RISK FACTOR; SIDE EFFECT; THORAX PAIN;

EID: 0347093526     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970405500114     Document Type: Article

References (16)

1. Brito RA, Medgyesy D, Zukowski TH, et al: Fluoropyrimidines: A critical evaluation. Oncology 57(suppl 1):2-8, 1999.
2. Cassidy J. Xeloda® in colorectal cancer. Int J Clin Pract 55:326-328, 2001.
3. www.rocheusa.com/products/xeloda/pi-only.htm
4. Cassidy J: Potential of Xeloda® in colorectal cancer and other solid tumors. Oncology 57(suppl 1):27-32, 1999.
5. Van Cutsem E, Twelves C, Cassidy J, et al, for the Xeloda Colorectal Cancer Study Group: Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: Results of a large phase III study. J Clin Oncol 19:4097-4106, 2001.
6. Blum JL: Xeloda® in the treatment of metastatic breast cancer. Oncology 57(suppl 1):16-20, 1999.
7. Kleiman NS, Lehane DE, Geyer CE, et al: Prinzmetal's angina during 5-fluorouracil chemotherapy. Am J Med 82:566-568, 1987.
8. Luwaert RJ, Descamps O, Majois F, et al: Coronary artery spasm induced by 5-fluorouracil. Eur Heart J 12:468-470, 1991.
9. Stefenelli T, Zielinski CC, Mayr H, et al: Prinzmetal's angina during cyclophosphamide therapy. Eur Heart J 9:1155-1157, 1988.
10. Aisner J, Van Echo DA, Whitacre M, et al: A phase I trial of continuous infusion VP-16-213 (etoposide). Cancer Chemother Pharmacol 7:157-160, 1982.
11. Doll DC, List AF, Greco A, et al: Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis. Ann Intern Med 105:48-51, 1986.
12. La Bianca R, Beretta G, Cierici M, et al: Cardiac toxicity of 5-fluorouracil: a study of 1083 patients. Tumori 68:505-510, 1982.
13. Allen A: The cardiotoxicity of chemotherapeutic drugs. Semin Oncol 19:529-542, 1992.
14. Rezkalla S, Kloner R, Ensley J, et al: Continuous ambulatory ECG monitoring during fluorouracil therapy: A prospective study. J Clin Oncol 7:509-514, 1989.
15. Freeman NJ, Constanza ME: 5-Fluorouracil associated cardiotoxicity. Cancer 61:36-45, 1988.
16. Mosseri M, Fingert HJ, Varticovski L, et al: In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle. Cancer Res 53:3028-3033, 1993.